Astra Zen has Sandoz and Amgen, JNJ or Pfizer is going to see the light soon! Mylan is cheap in its 52 week range so a deal is afoot!!
Amgen could be incredibly smart and control the future of the Biosim market with buying Mylan MYL not to mention its global footprint it has laid out! MYL would be a strategic move for AMGN!!
The problem is not necessarily AMGN but the ETF's in which it resides and there are 21. Some are small however XLV (AMGN = 4.5%) trades over 12 million shares per day and IBB (AMGN = 8.3%) trades about 2.25 million per day. So when the market does not like biotechs or in some instances healthcare in general AMGN still gets the #$%$ kicked out of it by being in a bad neighborhood. In addition, this spooks others to dump the stock because they are unaware that the downturn does not necessarily reflect how investors think about AMGN as an individual stock. Only ETFs I have ever owned are commodities and currencies which allows you to trade them without having a commodities broker.
Great earnings and a great outlook and down over $3/share. What would have happened if we only met expectations or actually came in below estimates? Down $20/share? Unbelievable!
Sentiment: Strong Buy
Too bad nobody else does. Robo traders trading off Biotech in general today so companies with actual good results get punished. Total nonsense.
i would say the wall street crooks were scooping up shares and that after earnings today they are going to make a pile of money...wall street at it's finest! watch it pop ten bucks tomorrow for all the good ol' boys...